secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scholar Rock Holding Corp (SRRK)
CIK:        0001727196
Form:       8-K
Filed at:   2024-02-15T23:59:59+00:00
Accession:  0001104659-24-024369
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scholar Rock adds Katie Peng to Board, promotes Mo Qatanani to CSO
------------------------------------------------------------------

- Katie Peng appointed to Board effective Feb 15, 2024; Class II director until 2026 annual meeting.
- Amir Nashat will not stand for reelection at 2024 annual meeting; stays on Board and Audit Committee until then.
- Peng brings commercial expertise in neurology and rare diseases, including launch of Evrysdi for SMA.
- Mo Qatanani promoted to Chief Scientific Officer; leads research and preclinical cardiometabolic program SRK-439.
- Company preparing for potential launch of apitegromab for SMA in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1727196/000110465924024369/0001104659-24-024369-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1727196/000110465924024369/tm246269d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-024369

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer